The gut microbiome across the cardiovascular risk spectrum.
Femke M PrinsValerie CollijHilde E GrootJohannes R BjörkJ Casper SwarteSergio Andreu-SánchezBernadien H JansenJingyuan FuHermie J M HarmsenAlexandra ZhernakovaErik LipsicPim van der HarstRinse K WeersmaRanko GacesaPublished in: European journal of preventive cardiology (2023)
We identified four microbial species showing a gradual trend in abundance from low-risk individuals to those with STEMI, and observed differential abundant species and pathways in STEMI patients compared to those without clinically manifest CAD. Further investigation is warranted to gain deeper understanding of their precise role in CAD progression and potential implications, with the ultimate goal of identifying novel therapeutic targets.